WebCompany type: Sociedad Limitada, Active: VAT Number (CIF) B02839470: Universal Entity Code: 8351-6250-1732-0076: Record last updated: Thursday, July 21, 2024 8:56:16 PM UTC WebApr 16, 2024 · Arch Biopartners Inc. has announced the signing of a licensing agreement with Telara Pharma SL for its patents relating to Cilastatin, dipeptidase-1 (DPEP-1) antagonists. The licensing deal which awards commercial rights for the patents, is put through mainly for Arch to use them in developing a treatment for acute kidney injury.
Genesis Biomed drives Telara Pharma, a spin-off from the …
WebPurdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the evolving needs of ... WebApr 14, 2024 · Clinical Specialist - SL Altamonte Springs, FL, USA * Florida, USA * Store 320, Altamonte Springs, Florida, United States of America Req #28843 … t4 free 1.0 ng/dl
Leanbio participates in a European project to boost nano …
WebScrip is part of Pharma Intelligence UK Limited. This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number … WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … WebMay 10, 2024 · Telara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the … t4 free by eia